
Apnimed
APMDPro trackingApnimed, Inc. · Nasdaq · Sleep-medicine biotechnology · Research source · 424B4 · Research as of 2026/07/31 · Latest filing · 10-Q · 2026-11-16 SEC ↗ · SEC checked 2026-11-21
Saved research available · 424B4
Apnimed priced its IPO at $16.00 per share, with 12.0 million shares offered and an FDA PDUFA goal date of February 28, 2027 for Oxnimbi.
Updates and this research have separate source dates; newer facts do not silently replace earlier conclusions.
Newly listed — review valuation, deal quality and post-IPO supply before acting
A clinical pharmaceutical company developing oral therapies for obstructive sleep apnea. The IPO priced at $16.00 and raised $192.00M.
Full source-backed summary
A clinical pharmaceutical company developing oral therapies for obstructive sleep apnea. The IPO priced at $16.00 and raised $192.00M. The latest market-value reference is $1.55B; reported revenue is $120.15M and net result is $(31.83M). The offer figures are reconciled to the final prospectus.
- Business and development direction
A clinical pharmaceutical company developing oral therapies for obstructive sleep apnea.
Current business Sleep-medicine biotechnology100%
Future development Future direction not yet disclosed
Key risks
Risk 1
Clinical development, regulatory approval and cash-runway outcomes can change the equity value materially.
Risk 2
The latest reported period remains loss-making.
Risk 3
The primary-secondary mix, controlling holders and voting rights require the final beneficial-ownership table.
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Offering quality | This saved report has no compatible source inputs for this calculation. Open filing ↗ |
| # | Institution | Underwriting allocation | Ratio · calculated | Shares |
|---|---|---|---|---|
| 1 | BofA Securities, Inc. | 38.00% | 4,560,000 shares | |
| 2 | Evercore Group L.L.C. | 28.50% | 3,420,000 shares | |
| 3 | Cantor Fitzgerald & Co. | 26.00% | 3,120,000 shares | |
| 4 | LifeSci Capital LLC | 7.50% | 900,000 shares |
Ratio = institution commitment ÷ complete source-table total (12,000,000 shares) × 100.
Underwriting terms
| Measure | Reported value | Unit |
|---|---|---|
| Underwriting discount per share | $1.12 | $ / share |
| Total underwriting discount | $13,440,000 | $ |
Source and calculation
Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 1 row 5; source 8279:24312; SHA256 e62a7025e91bf7dc8fa2da91466ab553ff7d00e3d9e71382c47ae8fc2c38ea2e ↗Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 1 row 5; source 8279:24312; SHA256 e62a7025e91bf7dc8fa2da91466ab553ff7d00e3d9e71382c47ae8fc2c38ea2e ↗IPO CAPITAL QUALITY
Basis and evidence
No estimate is substituted for missing offer terms.
Capital quality is not yet quantifiable from the filed terms. IPO177 will calculate it when primary/secondary shares, fees and net proceeds are all disclosed.
Offering structure
| Measure | Reported value | Unit |
|---|---|---|
| Shares offered | 12,000,000 | Shares |
| Offering price | $16 | $ / share |
| Gross offering amount | $192,000,000 | $ |
Source and calculation
Prospectus offering table; stated base scenario and source conditions Figures retain their stated source scenario and conditions.
Prospectus offering table; stated base scenario and source conditions
SEC table 4 row 2; source 158994:181121; SHA256 aa166683b149c5e55eaef610f0c8733f6841e88f60f9159e5b4c4ad439bf6c41 ↗Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 1 row 4; source 8279:24312; SHA256 e62a7025e91bf7dc8fa2da91466ab553ff7d00e3d9e71382c47ae8fc2c38ea2e ↗Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 1 row 4; source 8279:24312; SHA256 e62a7025e91bf7dc8fa2da91466ab553ff7d00e3d9e71382c47ae8fc2c38ea2e ↗Proceeds and intended uses
| Measure | Reported value | Unit |
|---|---|---|
| Issuer proceeds before expenses | $178,560,000 | $ |
Source and calculation
Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 1 row 6; source 8279:24312; SHA256 e62a7025e91bf7dc8fa2da91466ab553ff7d00e3d9e71382c47ae8fc2c38ea2e ↗Dilution and valuation
Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.
| Calculation | Shares | Value | Reference |
|---|---|---|---|
| Post-offer shares — as disclosed | 39,823,183 | — | |
| Post-offer shares — full option | 41,623,183 | — | |
| Capitalization shares — actual | 1,847,412 | — | |
| Capitalization shares — actual | 2,752,091 | — | |
| Capitalization shares — actual | 196,577 | — | |
| Capitalization shares — pro forma | 27,823,183 | — | |
| Capitalization shares — pro forma as adjusted | 39,823,183 | — | |
| Shares offered | 12,000,000 | — | |
| Offering price | — | $16 | |
| Gross offering amount | — | $192,000,000 |
Basis and evidence ↗
Prospectus share summary; Common stock to be outstanding immediately after this offering; 39,823,183 shares (41,623,183 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: as disclosed; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Common stock to be outstanding immediately after this offering; 39,823,183 shares (41,623,183 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: actual; Class A common stock, $0.00001 par value per share; 46,105,170 shares authorized, 1,847,412 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: actual; Class B common stock, $0.00001 par value per share; 2,948,668 shares authorized, 2,752,091 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: actual; Class C common stock, $0.00001 par value per share; 196,577 shares authorized, 196,577 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: pro forma; Common stock, $0.00001 par value per share; no shares authorized, issued or outstanding, actual; 500,000,000 shares authorized, 27,823,183 shares issued and outstanding, pro forma; 500,000,000 shares authorized, 39,823,183 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: pro forma as adjusted; Common stock, $0.00001 par value per share; no shares authorized, issued or outstanding, actual; 500,000,000 shares authorized, 27,823,183 shares issued and outstanding, pro forma; 500,000,000 shares authorized, 39,823,183 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Prospectus offering table; stated base scenario and source conditions
Prospectus offering table; stated base scenario and source conditions Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Exact input · Offering price: $16
Share-count comparison
Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.
Source ↗IPO valuation scenario simulator
Source inputs required
Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.
Source ↗Source and calculation ↗
Reported point prices retain their security, class, currency and per-security unit; range endpoints remain separate.
Compatible source-bound inputs are not available; absence is not a non-disclosure finding.
Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.
Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.
Each reported full-option, actual, diluted or class-specific case remains independent; no class sum or cross-date substitution is inferred.
Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.
The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.
These saved displays are not verified valuation inputs. Their stage, precision and assumptions have not been established by the current source.
IPO price · 12.000M · $192.00M · $16.00
Latest shares outstanding · 55.42M · $1.55B · Market snapshot
Revenue reference · — · $120.15M · Milestone-led
Net-result reference · — · $(31.83M) · Loss-making
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Ownership across stages | Comparable ownership figures across stages are unavailable in this report. See Control for holdings on their disclosed basis. Open filing ↗ |
Latest available filing
- Economic
- ~21.7%*
- As of
- 2026/07/31
Relationship filters
Select for details · Apnimed
Holdings and voting rights
Holder groups may overlap; these rows are not an additive ownership partition.
| Holder / measure | Shares | Ownership | Voting rights | Reference |
|---|---|---|---|---|
| our executive officers, directors, holders of 5% or more of our capital stock and their respective affiliatesOwnership as disclosed | — | approximately 85%Beneficial | — | Source statement; approximately ; source predicate: beneficially owned; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this offering by any of this group), in each case assuming the conversion of all outsta; source scope: of our voting stock and, upon the completion of this offering, that same group will hold approximately; not an additive ownership partition |
| our executive officers, directors, holders of 5% or more of our capital stock and their respective affiliatesOwnership as disclosed | — | approximately 59%Beneficial | — | Source statement; approximately ; source predicate: will hold; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this offering by any of this group), in each case assuming the conversion of all outsta; source scope: of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this; not an additive ownership partition |
| Columbia FundOwnership as disclosed | — | >5%Beneficial | — | Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition |
| ShionogiOwnership as disclosed | — | >5%Beneficial | — | Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition |
| TaoOwnership as disclosed | — | >5%Beneficial | — | Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition |
| Alpha WaveOwnership as disclosed | — | >5%Beneficial | — | Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition |
| Morningside, an affiliate of MVIL, LLCOwnership as disclosed | — | >5%Beneficial | — | Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition |
| ShionogiOwnership as disclosed | — | >5%Beneficial | — | Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition |
| MorningsideBeneficial shares | 6,915,837 | — | — | Number of sharesbeneficially owned |
| Alpha WaveBeneficial shares | 7,054,954 | — | — | Number of sharesbeneficially owned |
| ShionogiBeneficial shares | 2,953,817 | — | — | Number of sharesbeneficially owned |
| Columbia FundBeneficial shares | 4,298,843 | — | — | Number of sharesbeneficially owned |
| TaoBeneficial shares | 1,865,638 | — | — | Number of sharesbeneficially owned |
| Lawrence G. Miller, M.D.Beneficial shares | 2,451,036 | — | — | Number of sharesbeneficially owned |
| Dennis P. MolnarBeneficial shares | 664,452 | — | — | Number of sharesbeneficially owned |
| Ronald H. FarkasBeneficial shares | 502,298 | — | — | Number of sharesbeneficially owned |
| Joseph Avellone, M.D.Beneficial shares | 155,288 | — | — | Number of sharesbeneficially owned |
| Paul FonteyneBeneficial shares | 35,674 | — | — | Number of sharesbeneficially owned |
| Gary SenderBeneficial shares | 22,702 | — | — | Number of sharesbeneficially owned |
| Kevin R. LindBeneficial shares | 27,798 | — | — | Number of sharesbeneficially owned |
| MorningsideBeneficial ownership | — | 24.85%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| MorningsideBeneficial ownership | — | 17.36%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| Alpha WaveBeneficial ownership | — | 25.35%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| Alpha WaveBeneficial ownership | — | 17.71%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| ShionogiBeneficial ownership | — | 10.61%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| ShionogiBeneficial ownership | — | 7.42%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| Columbia FundBeneficial ownership | — | 15.45%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| Columbia FundBeneficial ownership | — | 10.79%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| TaoBeneficial ownership | — | 6.7%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| TaoBeneficial ownership | — | 4.68%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| Lawrence G. Miller, M.D.Beneficial ownership | — | 8.22%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| Lawrence G. Miller, M.D.Beneficial ownership | — | 5.86%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| Dennis P. MolnarBeneficial ownership | — | 2.34%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| Dennis P. MolnarBeneficial ownership | — | 1.64%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| Ronald H. FarkasBeneficial ownership | — | 1.77%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| Ronald H. FarkasBeneficial ownership | — | 1.25%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| All current directors and executive officers as a group (12 persons)Beneficial ownership | — | 10.95%Beneficial | — | Percentage ofshares beneficially owned; Beforeoffering |
| All current directors and executive officers as a group (12 persons)Beneficial ownership | — | 7.87%Beneficial | — | Percentage ofshares beneficially owned; Afteroffering |
| All current directors and executive officers as a group (12 persons)Beneficial shares | 3,356,950 | — | — | Number of sharesbeneficially owned |
| common stockper-share voting rights | — | — | 1 vote per shareVotes per share | Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding; Source capital-stock section conditions: source capital/articles apply at the stated offering completion or closing stage; complete original context retained |
Source and calculation ↗
Source statement; approximately ; source predicate: beneficially owned; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this offering by any of this group), in each case assuming the conversion of all outsta; source scope: of our voting stock and, upon the completion of this offering, that same group will hold approximately; not an additive ownership partition
Based on the beneficial ownership of our common stock as of July 8, 2026, prior to this offering, our executive officers, directors, holders of 5% or more of our capital stock and their respective affiliates beneficially owned approximately 85% of our voting stock and, upon the completion of this offering, that same group will hold approximately 59% of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this offering by any of this group), in each case assuming the conversion of all outstanding shares of our convertible preferred stock, Convertible Notes, Class B common stock and Class C common stock into shares of our Class A common stock. As a result, these stockholders, if acting together, will continue to have significant influence over the outcome of corporate actions requiring stockholder approval, including the election of directors, amendment of our organizational documents, any merger, consolidation or sale of all or substantially all of our assets and any other significant corporate transaction. Additionally, one of our principal stockholders, Alpha Wave, will have an employee who sits on our board of directors following the completion of this offering. The interests of these stockholders may not be the same as or may even conflict with your interests. For example, these stockholders could delay or prevent a change of control of our company, even if such a change of control would benefit our other stockholders, which could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company or our assets and might affect the prevailing market price of our common stock. The significant concentration of stock ownership may adversely affect the trading price of our common stock due to investors’ perception that conflicts of interest may exist or arise.
Source statement; approximately ; source predicate: will hold; primary source clause; source condition: assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this offering by any of this group), in each case assuming the conversion of all outsta; source scope: of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this; not an additive ownership partition
Based on the beneficial ownership of our common stock as of July 8, 2026, prior to this offering, our executive officers, directors, holders of 5% or more of our capital stock and their respective affiliates beneficially owned approximately 85% of our voting stock and, upon the completion of this offering, that same group will hold approximately 59% of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares, no exercise of outstanding options or the Warrants and no purchases of shares in this offering by any of this group), in each case assuming the conversion of all outstanding shares of our convertible preferred stock, Convertible Notes, Class B common stock and Class C common stock into shares of our Class A common stock. As a result, these stockholders, if acting together, will continue to have significant influence over the outcome of corporate actions requiring stockholder approval, including the election of directors, amendment of our organizational documents, any merger, consolidation or sale of all or substantially all of our assets and any other significant corporate transaction. Additionally, one of our principal stockholders, Alpha Wave, will have an employee who sits on our board of directors following the completion of this offering. The interests of these stockholders may not be the same as or may even conflict with your interests. For example, these stockholders could delay or prevent a change of control of our company, even if such a change of control would benefit our other stockholders, which could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company or our assets and might affect the prevailing market price of our common stock. The significant concentration of stock ownership may adversely affect the trading price of our common stock due to investors’ perception that conflicts of interest may exist or arise.
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition
Columbia Fund beneficially owns more than 5% of our outstanding capital stock.
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition
Shionogi beneficially owns more than 5% of our outstanding capital stock.
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition
Tao beneficially owns more than 5% of our outstanding capital stock.
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition
Alpha Wave beneficially owns more than 5% of our outstanding capital stock. Mr. Dimitropoulos currently serves as a member of our board of directors.
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition
Morningside, an affiliate of MVIL, LLC, beneficially owns more than 5% of our outstanding capital stock. Mr. Cheng previously served as a member of our board of directors as the designee of Morningside pursuant to the Voting Agreement, which terminates upon the closing of this offering.
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding capital stock; not an additive ownership partition
In November 2023, we entered into a Common Stock Purchase Agreement with Shionogi whereby we issued to Shionogi 2,752,091 shares of Class B common stock at a purchase price of approximately $12.72 per share and 196,577 shares of Class C common stock at a purchase price of approximately $12.72 per share, for a total purchase price of approximately $37.5 million. Shionogi beneficially owns more than 5% of our outstanding capital stock.
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Morningside(1)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Alpha Wave(2)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Shionogi(3)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Columbia Fund(4)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Tao(5)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Lawrence G. Miller, M.D.(6)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Dennis P. Molnar(7)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Ronald H. Farkas(8)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Joseph Avellone, M.D.(9)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Paul Fonteyne(12)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Gary Sender(13)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: Kevin R. Lind(14)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Morningside(1)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Morningside(1)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Alpha Wave(2)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Alpha Wave(2)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Shionogi(3)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Shionogi(3)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Columbia Fund(4)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Columbia Fund(4)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Tao(5)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Tao(5)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Lawrence G. Miller, M.D.(6)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Lawrence G. Miller, M.D.(6)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Dennis P. Molnar(7)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Dennis P. Molnar(7)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: Ronald H. Farkas(8)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: Ronald H. Farkas(8)
Exact source ownership column: Percentage ofshares beneficially owned; Beforeoffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Beforeoffering; source holder: All current directors and executive officers as a group (12 persons)(16)
Exact source ownership column: Percentage ofshares beneficially owned; Afteroffering; holders may overlap; not an additive partition
Raw source column: Percentage ofshares beneficially owned; Afteroffering; source holder: All current directors and executive officers as a group (12 persons)(16)
Exact source ownership column: Number of sharesbeneficially owned; holders may overlap; not an additive partition
Raw source column: Number of sharesbeneficially owned; source holder: All current directors and executive officers as a group (12 persons)(16)
Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding; Source capital-stock section conditions: source capital/articles apply at the stated offering completion or closing stage; complete original context retained
Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any dividends declared by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions. Source context: The following description of our capital stock and certain provisions of our ninth amended and restated certificate of incorporation and second amended and restated bylaws are summaries and are qualified by reference to the ninth amended and restated certificate of incorporation, which will become effective upon the closing of this offering, and the second amended and restated bylaws, which will become effective upon the closing of this offering. Copies of these documents have been filed with the SEC as exhibits to our registration statement, of which this prospectus forms a part. The descriptions of the common stock and preferred stock reflect changes to our capital structure that will be in effect on the closing of this offering.
Saved control snapshot
The dated saved report retains its own figures and assumptions. These strings are not new calculation inputs.
| Holder / measure | Shares | Ownership | Voting rights | Reference |
|---|---|---|---|---|
| Existing holdersMajor ownership group | — | ~78.3%* | — | |
| Other disclosed classesMajor ownership group | — | See filing | — | |
| IPO sharesPublic / new investors | — | 12.000M | — |
Economic ownership
A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.
IPO shares are immediately tradable; later supply depends on the final lock-up, option and resale-registration terms.
- Initial float
- 12.000M
- Restricted / potential supply
- 55.42M
- Multiple
- See filing
- Increase
- See filing
Share supply
Source lock-up conditions
Literal day restriction; after date of this prospectus; full conditions and exceptions remain in the source paragraph
| Measure | Reported value |
|---|---|
| We, our officers, directors and substantially all of our securityholdersAfter date of this prospectus · Source conditions apply | 180 days |
| We, our executive officers and directors and our other existing security holdersAfter date of this prospectus · Source conditions apply | 180 days |
Source and calculation
We, our officers, directors and substantially all of our securityholders have agreed with the underwriters that for a period of 180 days after the date of this prospectus, among other things and subject to certain exceptions, we or they will not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock, request or demand that we file a registration statement related to our common stock or enter into any swap or other agreement that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of the common stock, or publicly declare an intention to do any of the foregoing. Upon expiration of the lock-up period, certain of our stockholders will have the right to require us to register their shares under the Securities Act. See the subsection titled “—Registration Rights” below and the section titled “Description of Capital Stock—Registration Rights.”
SEC lock-up paragraph; source 4623260:4624887; SHA256 ad4c03e7703930a6508f90a6b7973daa77ad587adabbb1d7a7a64292f49491e3 ↗We, our executive officers and directors and our other existing security holders have agreed not to sell or transfer any common stock or securities convertible into, exchangeable for, exercisable for, or repayable with common stock (collectively, the Lock-Up Securities), for 180 days after the date of this prospectus without first obtaining the written consent of BofA Securities, Inc., Evercore Group, L.L.C. and Cantor Fitzgerald & Co. Specifically, we and these other persons have agreed, with certain limited exceptions, not to directly or indirectly:
SEC lock-up paragraph; source 4732185:4733155; SHA256 810383b8d30685e526e56ea2527f78ecaa29dca669a48fd9b01acb5afa14b11d ↗Conditional lock-up timeline
Conditional lock-up timeline
Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.
Milestones and unconfirmed releases
| Holder / event | Term / date | Conditions |
|---|---|---|
| Over-allotment window | Post-listing See filing · Additional shares only if exercised | Over-allotment window · Additional shares only if exercised |
| Insider resale eligibility | Holder-specific See 424B · Existing-holder supply | Insider resale eligibility · Existing-holder supply |
Basis and evidence
Over-allotment window · Additional shares only if exercised
Lock-up / shares eligible for future sale ↗Insider resale eligibility · Existing-holder supply
Lock-up / shares eligible for future sale ↗Financial quality
| Calculation | Reported value |
|---|---|
| General and administrative expenses3M ended 2026-03-31 · Consolidated · Unaudited | $6,506,000 |
| General and administrative expenses3M ended 2025-03-31 · Consolidated · Unaudited | $5,470,000 |
| Operating cash flow3M ended 2026-03-31 · Consolidated · Unaudited | ($19,812,000) |
| Operating cash flow3M ended 2025-03-31 · Consolidated · Unaudited | ($28,452,000) |
Basis and evidence
Saved snapshot — period not verified
These saved figures have no verified reporting period or currency basis. They are excluded from statement comparisons and calculations.
Financial quality
| Calculation | Reported value | Reference |
|---|---|---|
| Revenue | $120.15M | Milestone-led |
| Net result | $(31.83M) | Latest reported |
| Market-value reference | $1.55B | Post-listing snapshot |
| Shares outstanding | 55.42M | Latest reported |
| Offer size | $192.00M | 12.000M |
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Financial review | Reported financial figures are shown above. A cash-runway estimate needs compatible cash-flow and funding assumptions. Open filing ↗ |
Baseline filing — comparison pending
No source-comparable material changes identified in this report.
Why it mattersChanges dilution, public float and potential supply.
Evidence · 424B4 · 2026/07/31Why it mattersChanges valuation, proceeds and first-day return assumptions.
Evidence · 424B4 · 2026/07/31424B4
• Final prospectus source verified
• Trading began on 2026-07-31 at $16.00
Clinical development, regulatory approval and cash-runway outcomes can change the equity value materially.
- Potential impact
- High
- Evidence
- 424B4 · 2026/07/31 ↗
The latest reported period remains loss-making.
- Potential impact
- High
- Evidence
- 424B4 · 2026/07/31 ↗
The primary-secondary mix, controlling holders and voting rights require the final beneficial-ownership table.
- Potential impact
- High
- Evidence
- 424B4 · 2026/07/31 ↗
Option exercise, employee equity and lock-up expiry can expand tradable supply.
- Potential impact
- Medium
- Evidence
- 424B4 · 2026/07/31 ↗
Sources and calculation notes
Final prospectus, offer price, listing date and headline financial evidence reconciled
View the filing's actual first page +
